Showing 2401-2410 of 21408 results for "".
- AI-Powered Imaging Revolutionizes Early Glaucoma Detectionhttps://reachmd.com/news/ai-powered-imaging-revolutionizes-early-glaucoma-detection/2475149/AI-Powered Imaging is revolutionizing ophthalmology by enabling detection of glaucomatous changes at a stage before clinical methods can reveal functional loss, opening a new window to prevent irreversible vision damage. Early glaucoma
- Hypertension Management: The Impact of FDA's Two-Front Innovationhttps://reachmd.com/news/hypertension-management-the-impact-of-fdas-two-front-innovation/2475162/Clinicians face stubborn adherence gaps and variable patient responses in hypertension, yet the FDA approval of a three-agent single-tablet combination and emerging genetic insights are poised to transform management strategies. Despit
- GALDA Co-Director Explains Organization's Work and Impacthttps://reachmd.com/news/galda-co-director-explains-organizations-work-and-impact/2475382/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo
- GALDA Co-Director Explains Organization's Work and Impacthttps://reachmd.com/news/GALDA-Co-Director-Explains-Organizations-Work-Impact/2475171/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo
- New IL-13/IL-31R Bispecific Antibody Data Presented at EAACIhttps://reachmd.com/news/New-IL-13-IL-31R-Bispecific-Antibody-Data-Presented-EAACI/2475170/A new IL-13/IL-31R bispecific antibody demonstrated ability to simultaneously suppress the inflammatory and pruritogenic pathways in atopic dermatitis (AD), according to preclinical study data presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 in Glasgow, S
- Oculomics: A Non-Invasive Window into Systemic Diseaseshttps://reachmd.com/news/oculomics-a-non-invasive-window-into-systemic-diseases/2475136/As clinicians face the challenge of detecting systemic diseases before irreversible damage occurs, oculomics is emerging as a non-invasive window into cardiovascular, neurodegenerative, and oncologic pathology. Recent studies have expl
- Enhancing Dental Implants with Natural Sensory Feedbackhttps://reachmd.com/news/enhancing-dental-implants-with-natural-sensory-feedback/2475139/Restoring the biomechanics of natural dentition in implantology is a significant focus for oral surgeons, as emerging dental implant technologies now aim to replicate real-time sensory feedback and adaptive wear patterns. Traditional d
- Early Intensive Therapy and Immunization in Psoriatic Arthritishttps://reachmd.com/news/early-intensive-therapy-and-immunization-in-psoriatic-arthritis/2475137/Early intensive therapy in psoriatic arthritis (PsA) and robust immunization protocols are redefining care pathways, offering the potential to alter disease trajectories and protect patients from complications of immunosuppression. Rhe
- Harnessing Llama Antibodies and VR for Infection Preventionhttps://reachmd.com/news/harnessing-llama-antibodies-and-vr-for-infection-prevention/2475128/Harnessing llama-derived antibodies and immersive virtual reality training marks a new frontier in preventing and containing infections that evade traditional controls. Healthcare-associated infections continue to challenge clinicians,
- Emerging Synergies in Combating Antimicrobial Resistance: Education Meets Innovationhttps://reachmd.com/news/emerging-synergies-in-combating-antimicrobial-resistance-education-meets-innovation/2475129/Antimicrobial resistance is eroding the effectiveness of cornerstone therapies and accelerating the emergence of drug-resistant pathogens, demanding simultaneous amplification of public understanding and rapid incorporation of novel treatment